MiniMed Flex pump
MiniMed
MiniMed's FDA-cleared, screenless, smartphone-controlled tubed pump: about half the size of the 780G, with app bolusing, a 300-unit reservoir, rechargeable battery lasting at least seven days, waterproofing and Simplera Sync compatibility. US commercial launch began on 17 June 2026.
The scorecard
US launch began with Simplera Sync; MiniMed started commercially shipping Flex with the Abbott-built Instinct sensor on 17 August 2026. Still a closed MiniMed ecosystem rather than an open pump.[6]
FDA-cleared and built on MiniMed's mature pump/SmartGuard lineage, but the Flex hardware itself lacks long real-world track record.[2]
Small and screenless, about half the 780G form factor, but still a tubed pump rather than a patch pump.[2]
Designed around MiniMed app control, including meal and correction boluses from a compatible device.[1]
300-unit reservoir and a rechargeable battery lasting at least seven days are strong for a compact pump; it also works with MiniMed's Extended infusion set, worn up to seven days.[4]
US commercial launch began on 17 June 2026, following March 2026 FDA clearance (type 1 diabetes from age 7, and adults 18+ with insulin-requiring type 2). Medicare and Medicare Advantage access began on 22 July; ex-US availability is still ahead.[5]
The full picture
MiniMed Flex is the hardware shift in MiniMed's next generation: a screenless tubed pump controlled through the MiniMed app. It preserves the 300-unit capacity and MiniMed infusion-set ecosystem while shrinking the pump and moving bolusing to the phone. Its ranking is deliberately split from the AID-system page: this pump score is about hardware access, form factor and interoperability; the AID page covers SmartGuard automation and the GATEWAY no-meal-bolus signal.
It is now actually shipping
Flex has moved from "cleared" to "on sale". MiniMed announced the start of its first US commercial launch on 17 June 2026, following FDA clearance in March 2026.1 It is indicated for type 1 diabetes from age 7, and for adults 18 and over with insulin-requiring type 2 diabetes. The pump launches with the Simplera Sync sensor, has no screen (control is entirely through the MiniMed app on iOS or Android from day one), holds 300 units, and works with MiniMed's infusion sets — including the Extended set, worn for up to seven days.1 That is why the access score moves up: this is a product you can be prescribed today rather than a clearance you are waiting on. It is still a US-only launch, and payer coverage is only starting to fall into place, which is what keeps the score in the middle of the range rather than near the top.
On 22 July 2026, MiniMed expanded US access to Medicare and Medicare Advantage beneficiaries.2 On 17 August 2026 MiniMed announced that Flex is commercially shipping in the US with Instinct, so customers can now order Flex with Instinct or Simplera Sync; existing Flex users need MiniMed app 1.3.1 plus a pump-software update to pair Instinct.3 Shipping is not Flex-specific outcome data. Separate claims of a European launch targeted for early 2027 and a Vivera algorithm software update in 2027 still rest on conference reporting and remain indicative rather than committed.4
References
-
Drug Delivery Business News. MiniMed begins miniature Flex pump rollout in US. Drug Delivery Business News (17 June 2026). https://www.drugdeliverybusiness.com/minimed-begins-flex-pump-rollout-us/ ↩ ↩2
-
MiniMed. MiniMed Flex Now Available to Medicare and Medicare Advantage Beneficiaries (22 July 2026). https://news.minimed.com/2026-07-22-MiniMed-Flex-TM-Now-Available-to-Medicare-and-Medicare-Advantage-Beneficiaries ↩
-
MiniMed. MiniMed's Smallest App-Controlled Insulin Pump Now Shipping with the World's Smallest Sensor (17 August 2026). https://www.prnewswire.com/news-releases/minimeds-smallest-app-controlled-insulin-pump-now-shipping-with-the-worlds-smallest-sensor-302852467.html ↩
-
Diabetotech. Closed-loop updates from ADA 2026. Diabetotech (2026). https://www.diabetotech.com/blog/closed-loop-updates-from-ada-2026 — conference reporting, not a manufacturer statement. ↩
What's next for this
- →Instinct with Flex — US shipping began 17 August 2026. Remaining work is broader inventory/payer coverage, not the pairing itself.
Sources
- [1]MiniMed Flex system product FAQ · manufacturer
- [2]MiniMed announces FDA clearance of MiniMed Flex, its smallest insulin pump and first smartphone-controlled design · manufacturer · 2026-03-18
- [3]GATEWAY safety evaluation of MiniMed NMX8-AID / Flex (NCT07228117) · registry
- [4]MiniMed begins miniature Flex pump rollout in US · news · 2026-06-17
- [5]MiniMed Flex now available to Medicare and Medicare Advantage beneficiaries · manufacturer · 2026-07-22 — Confirms current US Medicare access and says the launched Simplera Sync configuration will gain Abbott-made Instinct compatibility later in summer 2026.
- [6]MiniMed's Smallest App-Controlled Insulin Pump Now Shipping with the World's Smallest Sensor · manufacturer · 2026-08-17 — MiniMed Flex now commercially shipping in the US with Instinct (Abbott). Customers can order Flex with Instinct or Simplera Sync. Shipping is not the same as Flex-specific glycemic outcomes.
- [7]Closed-loop updates from ADA 2026 (conference reporting) · conference — Conference round-up, not a MiniMed statement — the European launch and Vivera software-update timelines below rest on this reporting alone.